Companies combining expertise to increase the number of late-stage lung cancer patients realizing extended survival from immunotherapy Rocky Hill, CT and Pinneberg, Germany – February 15, 2023 – Lumeda Inc, a clinical-stage medical technology company focused on improving treatment outcomes of patients with lung cancer, and photonamic GmbH & Co KG, a pharmaceutical company involved in the development of 5-aminolevulinic …
Lumeda Management Team Included in Hartford Business Journal’s Second Annual Power 25 Health Care List
Identifies leaders significantly impacting the healthcare industry and public health Lumeda Management Team Included in Hartford Business Journal’s Second Annual Power 25 Health Care List Identifies leaders significantly impacting the healthcare industry and public health Rocky Hill, Connecticut – October 28, 2021 – Lumeda Inc., a medical technology company advancing photodynamic therapy (PDT) as an intraoperative adjuvant treatment for patients …
Lumeda Announces Closing of $4.3M Series A Financing with Clinical Studies Due to Commence in 2021
Funding to advance product design and clinical testing as the company strives to improve outcomes for lung cancer patients Rocky Hill, Connecticut – April 8, 2021 – Lumeda Inc., a medical technology company advancing Photodynamic Therapy (PDT) as an intraoperative adjuvant treatment for patients during lung cancer surgery, today announced the closing of its Series A financing. The round was …
Lumeda Announces Appointment of Alexander Zinke as Chief Executive Officer
Experienced medical industry executive to lead the company in its next phase of commercialization and growth Rocky Hill, Connecticut – October 15, 2020 – Lumeda Inc., a biophotonics systems company advancing photodynamic therapy (PDT) for treating cancer, today announced the appointment of Alexander (Sandy) Zinke as Chief Executive Officer. Mr. Zinke will also join the company board of directors. …
Lumeda Announces Formation of its Scientific Advisory Board
Prominent medical and scientific experts to help company advance development of PDT products Rocky Hill, Connecticut – June 22, 2020 – Lumeda Inc. (“Lumeda”), a biophotonics systems company advancing photodynamic therapy (PDT) for treating cancer, today announced the formation of its Scientific Advisory Board with the appointment of a panel of medical and scientific experts who will provide critical medical, …
Lumeda Enters License Agreement with Roswell Park Comprehensive Cancer Center
Company secures exclusive rights for intraoperative photodynamic therapy in the treatment of non-small cell lung cancer Rocky Hill, Connecticut – June 25, 2020 – Lumeda Inc. (“Lumeda”), a biophotonics systems company formed to advance photodynamic therapy for treating cancer, today announced the company has entered a license agreement with Roswell Park Comprehensive Cancer Center of Buffalo, New York (“Roswell Park”). …
